EFG Asset Management (Americas)’s Abiomed Inc ABMD Stock Holding History

EFG Asset Management (Americas)’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-913	Closed	-$302K	–	139
2022 Q1	$302K	Sell	913 -130	-12%	-$40K	0.06%	123
2021 Q4	$375K	Buy	1,043 +14	+1%	+$4.73K	0.06%	122
2021 Q3	$335K	Sell	1,029 -3	-0.3%	-$1.02K	0.06%	125
2021 Q2	$322K	Buy	1,032 +149	+17%	+$45.7K	0.06%	129
2021 Q1	$281K	Buy	883 +78	+10%	+$25K	0.06%	128
2020 Q4	$261K	Sell	805 -26	-3%	-$7.19K	0.05%	128
2020 Q3	$230K	Buy	+831	New	+$239K	0.05%	130
2019 Q4	–	Sell	-10,034	Closed	-$1.78M	–	127
2019 Q3	$1.78M	Sell	10,034 -2	-0%	-$432	0.54%	67
2019 Q2	$2.61M	Buy	10,036 +880	+10%	+$233K	0.74%	61
2019 Q1	$2.62M	Buy	9,156 +696	+8%	+$231K	0.79%	55
2018 Q4	$2.75M	Buy	8,460 +902	+12%	+$313K	0.99%	43
2018 Q3	$3.4M	Buy	7,558 +3,400	+82%	+$1.34M	0.97%	38
2018 Q2	$1.7M	Buy	4,158 +1,982	+91%	+$718K	0.51%	63
2018 Q1	$633K	Buy	+2,176	New	+$551K	0.26%	81

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EFG Asset Management (Americas)'s ABMD Position: Q2 2022 in Review

EFG Asset Management (Americas) sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 913 shares — an estimated $302K sold.

EFG Asset Management (Americas) first reported a position in ABMD in Q1 2018 and held it in 14 quarters. The position peaked at $3.4M in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

EFG Asset Management (Americas) reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
EFG Asset Management (Americas) sold 913 Abiomed Inc shares in Q2 2022, an estimated $302K.
EFG Asset Management (Americas) first reported a position in Abiomed Inc in Q1 2018 and held it in 14 quarters.
EFG Asset Management (Americas)'s Abiomed Inc position peaked at $3.4M in Q3 2018.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on EFG Asset Management (Americas)'s 13F filing for Q2 2022, filed 13 Jul 2022.